Benzazepine derivatives as alpha-v integrin receptor antagonists
CA 2358855 A1 · Owner: Askew, Ben C. · Inventors: Askew, Ben C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to benzazepine derivatives and their use as alpha-V integrin receptor antagonists. More particularly the compounds of the , present invention are antagonists of the integrin receptors alphaVbeta3 alphaVbeta5, and/or alphaVbeta6 and are useful for inhibiting bone resorption treating and preventing osteoporosis, and inhibiting vascular restenosis diabetic retinopathy, macular degeneration angiogenesis, atherosclerosis, inflammation wound healing, viral disease, tumor growth and metastasis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 31, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 31, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 31, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.